This week on "The Top Line," we explore biopharma layoffs in the first quarter of 2024.
Using data from Fierce Biotech's layoff tracker, Gabrielle Masson and Max Bayer analyze the trends of layoffs in the first quarter of 2024, comparing them to previous years. With a notable number of layoff rounds marking the start of the year, they examine the factors behind this ongoing challenge while also highlighting positive industry developments.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Exploring AstraZeneca's environmental pledges
Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies
[SPONSORED] Accelerate and Optimize Rare Disease Patient-Finding with AI
August 18, 2023
August 11, 2023
August 4, 2023
July 28, 2023
July 21, 2023
July 14, 2023
[Sponsored] Clinical trial technologies support recruitment efforts
July 7, 2023
June 30, 2023
June 23, 2023
June 16, 2023
June 9, 2023
[Sponsored] Addressing the patient centricity challenge with ZS Associates
June 2, 2023
May 26, 2023
May 19, 2023
May 12, 2023
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Børsen Morgenbriefing
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast